Spectral Peak Frequency in Low-Frequency Band in Cross Spectra of Blood Pressure and Heart Rate Fluctuations in Young Type 1 Diabetic Patients

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

HONZÍKOVÁ Nataša KRTIČKA Antonín ZÁVODNÁ Eva JAVORKA M. TONHAJZEROVÁ I. JAVORKA K.

Year of publication 2012
Type Article in Periodical
Magazine / Source Physiological Research
MU Faculty or unit

Faculty of Medicine

Citation
Field Endocrinology, diabetology, metabolism, nutrition
Keywords Type 1 diabetes mellitus; Baroreflex sensitivity; Cross-spectral analysis; Frequency of spectral peak; Receiver operating curve
Description In this study we tested whether joint evaluation of the frequency (fcs) at which maxima of power in the cross-spectra between the variability in systolic blood pressure and inter-beat intervals in the range of 0.06-0.12 Hz occur together with the quantification of baroreflex sensitivity (BRS) may improve early detection of autonomic dysfunction in type 1 diabetes mellitus (T1DM). We measured 14 T1DM patients (age 20.3-24.2 years, DM duration 10.4-14.2 years, without any signs of autonomic neuropathy) and 14 age-matched controls (Co). Finger arterial blood pressure was continuously recorded by Finapres for one hour. BRS and fcs were determined by the spectral method. Receiver-operating curves (ROC) were calculated for fcs, BRS, and a combination of both factors determined as F(z)=1/(1+exp(-z)), z=3.09–0.013*BRS– 0.027*fcs. T1DM had significantly lower fcs than Co (T1DM: 88.8plusminus 6.7 vs. Co: 93.7plusminus 3.8 mHz; p<0.05), and a tendency towards lower BRS compared to Co (T1DM: 10.3 plusminus 4.4 vs. Co: 14.6plusminus 7.1 ms/mm Hg; p=0.06). The ROC for Fz showed the highest sensitivity and specificity (71.4 % and 71.4 %) in comparison with BRS (64.3 % and 71.4 %) or fcs (64.3 % and 64.3 %). The presented method of evaluation of BRS and fcs forming an integrated factor Fz could provide further improvement in the risk stratification of diabetic patients.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info